Philips launches high-field MR

Article

The Intera Enterprise, a 1.5T scanner, has risen to the upper end of MR offerings at Philips Medical Systems. The new product, currently available only in the U.S., is being marketed primarily to privately owned imaging centers, according to the company.

The Intera Enterprise, a 1.5T scanner, has risen to the upper end of MR offerings at Philips Medical Systems. The new product, currently available only in the U.S., is being marketed primarily to privately owned imaging centers, according to the company. The short-bore Intera Enterprise, announced July 24, also comes in a mobile configuration. Philips executives view the entrepreneurial marketplace as an opportunity for growth. They claim a 30% share in MR sales to this U.S. market segment. The four-channel radio-frequency system supports optimized packages for neuro, orthopedic, body, cardiac, and vascular applications.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.